PACS Group, Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the PACS Group, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, PACS Group, Inc. has logged 112 public disclosures. Market capitalisation: €6.7bn. The latest transaction was reported on 9 September 2026 (Cession). Among the most active insiders: Hancock Mark. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,988 of 29,063 companies
FCF yld 2.3%
Earn yld 2.9%
EV/EBITDA 27.6x
ROE 28%
Gross mgn 15%
Net mgn 3.6%
Debt/EBITDA 9.4x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives112 Thresholds0 Prospectus0 Other0
Declarations 112 total
▼ Co-Founder, CEO & Chairman · Executives · 4 Sept 2026
22,829 shares @ US$42.6832 Common Stock SEC:0002014386-26-000012:0
▼ Co-Founder, CEO & Chairman · Executives · 4 Sept 2026
243 shares @ US$43.1445 Common Stock SEC:0002014386-26-000012:1
▼ Co-Founder, CEO & Chairman · Executives · 8 Sept 2026
3,056 shares @ US$42.8001 Common Stock SEC:0002014386-26-000012:2
▼ Co-Founder, CEO & Chairman · Executives · 8 Sept 2026
21,001 shares @ US$43.5946 Common Stock SEC:0002014386-26-000012:3
▼ Co-Founder, CEO & Chairman · Executives · 9 Sept 2026
4,758 shares @ US$43.3264 Common Stock SEC:0002014386-26-000012:4
▼ Co-Founder, CEO & Chairman · Executives · 1 Sept 2026
22,789 shares @ US$42.3519 0.014% mcap 0.3% of flow Common Stock SEC:0002014386-26-000010:0
▼ Co-Founder, CEO & Chairman · Executives · 1 Sept 2026
1,368 shares @ US$43.0484 0.0009% mcap 0.0% of flow Common Stock SEC:0002014386-26-000010:1
▼ Co-Founder, CEO & Chairman · Executives · 2 Sept 2026
17,435 shares @ US$42.7845 0.011% mcap 0.2% of flow Common Stock SEC:0002014386-26-000010:2
▼ Co-Founder, CEO & Chairman · Executives · 2 Sept 2026
6,348 shares @ US$43.3639 0.0041% mcap 0.1% of flow Common Stock SEC:0002014386-26-000010:3
▼ Co-Founder, CEO & Chairman · Executives · 3 Sept 2026
19,315 shares @ US$42.5315 0.012% mcap 0.2% of flow Common Stock SEC:0002014386-26-000010:4
▼ Co-Founder, CEO & Chairman · Executives · 3 Sept 2026
858 shares @ US$43.1088 0.0006% mcap 0.0% of flow Common Stock SEC:0002014386-26-000010:5
● Director · Executives · 18 Aug 2026
88,000 shares 0Common Stock SEC:0002014361-26-000032:0
▼ Director · Executives · 14 Aug 2026
3,497 shares @ US$44.41 0.0023% mcap 100.0% of flow Common Stock SEC:0002067754-26-000010:0
▼ Co-Founder, CEO & Chairman · Executives · 20 Aug 2026
77,427 shares @ US$43.7714 0.048% mcap 0.9% of flow Common Stock SEC:0002014386-26-000008:0
▼ Co-Founder, CEO & Chairman · Executives · 20 Aug 2026
13,879 shares @ US$44.7625 0.0089% mcap 0.2% of flow Common Stock SEC:0002014386-26-000008:1
▼ Co-Founder, CEO & Chairman · Executives · 21 Aug 2026
31,654 shares @ US$43.6063 0.020% mcap 0.4% of flow Common Stock SEC:0002014386-26-000008:2
▼ Co-Founder, CEO & Chairman · Executives · 21 Aug 2026
27,590 shares @ US$44.2469 0.017% mcap 0.3% of flow Common Stock SEC:0002014386-26-000008:3
▼ Co-Founder, CEO & Chairman · Executives · 17 Aug 2026
9,758 shares @ US$43.3416 0.0061% mcap 0.1% of flow Common Stock SEC:0002014386-26-000006:0
▼ Co-Founder, CEO & Chairman · Executives · 17 Aug 2026
74,844 shares @ US$44.2704 0.048% mcap 0.9% of flow Common Stock SEC:0002014386-26-000006:1
▼ Co-Founder, CEO & Chairman · Executives · 18 Aug 2026
66,797 shares @ US$44.1807 0.042% mcap 0.8% of flow Common Stock SEC:0002014386-26-000006:2
▼ Co-Founder, CEO & Chairman · Executives · 19 Aug 2026
84,650 shares @ US$44.2645 0.054% mcap 1.0% of flow Common Stock SEC:0002014386-26-000006:3
▼ Co-Founder, CEO & Chairman · Executives · 19 Aug 2026
67 shares @ US$44.8472 0.0000% mcap 0.0% of flow Common Stock SEC:0002014386-26-000006:4
● Officer, Director, 10% Stockholder · Executives · 17 Aug 2026
386,666 shares @ US$43.69 0.24% mcap 4.6% of flow Common SEC144:0001969223-26-000913
▼ President & COO · Executives · 12 Aug 2026
3,625 shares @ US$44.5299 0.0022% mcap 0.8% of flow Common Stock SEC:0002014275-26-000012:0
▼ President & COO · Executives · 12 Aug 2026
36,375 shares @ US$45.6981 0.023% mcap 8.6% of flow Common Stock SEC:0002014275-26-000012:1
25 of 112 declarations
Load more (87 remaining) 关于 PACS Group, Inc. PACS Group, Inc.是一家美国上市医疗保健公司,在纽约证券交易所(NYSE)以代码PACS交易,总部位于美国。对于法语投资者而言,该公司应被视为一个急性后期护理和老年住房平台,而不是纯粹的房地产或通用医疗保健名称。PACS成立于2013年,最初只有两家熟练护理设施,此后已扩展为美国最大的急性后期运营商之一,在17个州拥有300多个附属设施。其企业总部位于犹他州盐湖城。
公司的商业模式结合了设施运营和集中支持服务。PACS主要专注于熟练护理设施,同时也参与老年生活,包括辅助生活和独立生活,以及康复和记忆护理服务。通过其支持平台PACS Services,公司提供行政和运营职能,如会计、财务、人力资源、工资单、信息技术、合规、法律、风险管理和企业通信。这一结构旨在让当地设施领导力专注于护理提供,同时受益于集中规模、系统和合规监督。
从竞争角度看,PACS强调其地理密度、规模和高效整合设施的能力。管理层将公司描述为美国按设施数量计算的最大熟练护理提供商之一。在这个高度监管、劳动密集的行业中,规模很重要,因为它可以改善与医院和卫生系统的转诊关系、支持运营杠杆,并增强公司吸收和改善表现不佳资产的能力。该平台扩展的足迹也为其提供了更广泛的基础,用于入住率恢复、临床组合改善和运营优化。
最近的发展一直是建设性的。PACS报告了2026年第一季度业绩,显示稳健的收入增长和更强的盈利能力,并提高了其2026年调整后EBITDA展望。公司还继续执行收购和投资组合扩张,2026年第一季度末拥有324项医疗保健运营,遍布17个州。2026年5月,董事会还批准了250 million美元的股票回购授权,强调了管理层对业务和资本结构的信心。
对投资者而言,PACS提供了与老龄化人口相关的美国人口结构顺风的敞口,但它也承担了急性后期护理的典型风险:报销压力、监管审查、员工成本和整合执行风险。总的来说,它是一个规模化、增长导向的急性后期护理平台,具有强大的运营焦点和明确界定的扩张战略。